About Ark Biotech
Ark Biotech is a company based in Boston (United States) founded in 2021 by Yossi Quint. Ark Biotech has raised $10.68 million across 2 funding rounds from investors including Primary. Ark Biotech offers products and services including Simulation Software and Bioreactor Model. Ark Biotech operates in a competitive market with competitors including PBS Biotech, Hyalose, Distek, ReelReactor and Choncept, among others.
- Headquarter Boston, United States
- Founders Yossi Quint
-
Sectors
ConsumerHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10.68 M (USD)
in 2 rounds
-
Latest Funding Round
$8.18 M (USD), Series A
May 10, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ark Biotech
Ark Biotech offers a comprehensive portfolio of products and services, including Simulation Software and Bioreactor Model.
Software for virtual bioreactor simulations to optimize bioprocess parameters.
Tool for predicting cell culture trends and scaling processes efficiently.
People of Ark Biotech
Unlock access to complete
Software Development Team
1 people
Leadership Team
1 people
Senior Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of Ark Biotech
Ark Biotech has successfully raised a total of $10.68M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $8.18 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ark Biotech
Ark Biotech has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Primary.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in seed-stage companies are managed by Primary Venture Partner.
|
Locked | Locked | Locked |
Investor details for Ark Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ark Biotech
Investment portfolio details for Ark Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ark Biotech
Detailed financials for Ark Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ark Biotech Comparisons
Peer comparison for Ark Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ark Biotech
Ark Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PBS Biotech, Hyalose, Distek, ReelReactor and Choncept, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies
|
|
| Locked | Locked | Locked |
Recombinant hyaluronic acid is manufactured in varying molecular sizes.
|
|
| Locked | Locked | Locked |
Produces dissolution apparatus and bioprocessing equipment for pharmaceutical testing.
|
|
| Locked | Locked | Locked |
Continuous reactor developed for biological products and therapies production.
|
|
| Locked | Locked | Locked |
Develops innovative chondroitin technologies through recombinant bacteria fermentation.
|
Detailed competitors of Ark Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ark Biotech
Complete news archive for Ark Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ark Biotech
Ark Biotech was founded in 2021.
Ark Biotech is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Yossi Quint is the current CEO of Ark Biotech. They have also founded this company.
Ark Biotech is a funded company, having raised a total of $10.68M across 2 funding rounds to date.
Ark Biotech was founded in 2021 and is based in Boston, United States. Operations focus on the biotechnology sector, where bioreactors and associated operating systems are manufactured for the industrial-scale production of cultivated meat. Development efforts target scalable solutions to support this emerging protein technology, with activities centered on hardware and software integration for efficient cultivation processes.
Ark Biotech's top competitors include PBS Biotech, Hyalose and ReelReactor.
Ark Biotech offers Simulation Software and Bioreactor Model.
Ark Biotech has 1 investor. Key investors include Primary.